Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity

We evaluated serologic response of 42 Middle East respiratory syndrome coronavirus (MERS-CoV)-infected patients according to four severity groups: asymptomatic infection (group 0), symptomatic infection without pneumonia (group 1), pneumonia without respiratory failure (group 2), and pneumonia progressing to respiratory failure (group 3). None of the group 0 patients showed seroconversion, while the seroconversion rate gradually increased with increasing disease severity (0.0%, 60.0%, 93.8%, and 100% in group 0, 1, 2, 3, respectively; P = 0.001).

Source: Diagnostic Microbiology and Infectious Disease - July 13, 2017 Category: Microbiology Authors: Jae-Hoon Ko, Marcel A. M üller, Hyeri Seok, Ga Eun Park, Ji Yeon Lee, Sun Young Cho, Young Eun Ha, Jin Yang Baek, So Hyun Kim, Ji-Man Kang, Yae-Jean Kim, Ik Joon Jo, Chi Ryang Chung, Myong-Joon Hahn, Christian Drosten, Cheol-In Kang, Doo Ryeon Chung, Jae Source Type: research